Interview with Dieter Torheiden, Managing Director, Solvay Australia
How will the PBS reforms affect Solvay? The easy answer is: heavily. Fortunately, Solvay’s leading product which is still under patent will not be subject to the full August 1…
Address: 20-22 McPherson St, Banksmeadow 2019, NSW,,Australia
Tel: 61-2-93168000
Web: http://www.solvayinterox.com.au/
Solvay Interox is the world’s leading producer of hydrogen peroxide and its derivatives, with production facilities worldwide. Solvay Interox Pty Ltd in Australia is wholly owned by Solvay and is a member of the worldwide Solvay Group of chemical and pharmaceutical companies. Solvay Interox in Australia is based in Banksmeadow, NSW and serves the peroxygen needs of Australia, New Zealand and the SW Pacific Islands. Solvay Interox’s Quality Management System is registered to the ISO 9002:1994 International Quality Standard for our hydrogen peroxide manufacturing facility and supporting corporate functions. We also actively support the Responsible Care ® initiative as a priority business guideline.
Hydrogen Peroxide
How will the PBS reforms affect Solvay? The easy answer is: heavily. Fortunately, Solvay’s leading product which is still under patent will not be subject to the full August 1…
Can you outline the significance of the current PBS to the industry and in particular the impact it has on service providers to the industry such as Hahn? As service…
Speaking to the Australian environment, how would you rate the market in terms of companies like Swisse? After traveling the world, the Australian market has shown to be one of…
In our interviews we have been hearing two opinions on the success of PBS reforms: that it works as it should in providing space for innovative medicine listings, and that…
Dr Bernadette Morris-Smith has also participated in this interview TranScrip Partners is by now a well-established player in the UK but a new player in Asia Pacific. Would you begin…
Dr. Reddy’s entered Australia under your leadership. Would you outline the key milestones & achievements? Our first product was available to us for commercialization in Jan 2010 and since then…
“Australia is not just a postbox for selling drugs; Celgene is committed to establishing a major presence in the region,” you said when Focus Reports met you first in 2008.…
Dr. Reddy’s entered Australia under your leadership. Would you outline the key milestones & achievements? Our first product was available to us for commercialization in Jan 2010 and since then…
Senior Partner Dr Sree Haran has also participated in this interview. TranScrip Partners is by now a well-established player in the UK but a new player in Asia Pacific. Would…
The company underwent some landmark changes under your leadership, changing the balance between different pillars of the business – retail, wholesale product delivery, marketing programs. Would you begin by outlining…
After just six months in the country, Novartis Australia’s new Managing Director offers his perspectives on the Australian pharmaceutical market and healthcare system, his company’s commitment to R&D, and…
Can you start by commenting on the state of diabetes in Australia at present? According to 2011 statistics nearly one million Australians have diabetes and about half of those are…
Would you begin by outlining the key milestones & achievements of the NHMRC in the past four years? The first point is the development of our initiatives on an international…
See our Cookie Privacy Policy Here
